125 related articles for article (PubMed ID: 8911159)
61. Molecular imaging in the management of cervical cancer.
Lai CH; Yen TC; Ng KK
J Formos Med Assoc; 2012 Aug; 111(8):412-20. PubMed ID: 22939658
[TBL] [Abstract][Full Text] [Related]
62. MRI of carcinoma of the cervix.
Thornbury JR
Urol Radiol; 1989; 11(4):230-2. PubMed ID: 2692272
[TBL] [Abstract][Full Text] [Related]
63. [Invasive carcinoma of the cervix uteri (stage IB-IIB): evaluation using magnetic resonance].
Sironi S; Belloni C; Taccagni L; Del Maschio A
Radiol Med; 1990 Sep; 80(3):314-20. PubMed ID: 2236692
[TBL] [Abstract][Full Text] [Related]
64. [Role of X-ray computed tomography in the evaluation of prognosis of cervical carcinoma].
Yamada E
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):205-12. PubMed ID: 2013709
[TBL] [Abstract][Full Text] [Related]
65. Endoluminal ultrasonic scanning in the staging of cervical carcinomas.
Dragsted J; Asmussen M; Gammelgaard J; Bock JE
Gynecol Oncol; 1987 Sep; 28(1):1-7. PubMed ID: 3308652
[TBL] [Abstract][Full Text] [Related]
66. Cervical Cancer as a silent killer: A rare case report with review of literature.
Pandey D; Shetty J; Sambhaji C; Saxena PU; Mishra D; Chawla A
J Cancer Res Ther; 2015; 11(3):653. PubMed ID: 26458635
[TBL] [Abstract][Full Text] [Related]
67. Ultrasound and computed tomographic findings in aggressive angiomyxoma of the uterine cervix.
Yaghoobian J; Zinn D; Ramanathan K; Pinck RL; Hilfer J
J Ultrasound Med; 1987 Apr; 6(4):209-12. PubMed ID: 3295287
[No Abstract] [Full Text] [Related]
68. The use of computerized tomography to obviate celiotomy in recurrent carcinoma of the cervix.
Walton LA; McCartney WH; Vesterinen E
Gynecol Oncol; 1981 Oct; 12(2 Pt 1):166-76. PubMed ID: 7297928
[No Abstract] [Full Text] [Related]
69. Computed tomography in the evaluation of advanced cervical cancer.
Ragni N; Bentivoglio G; Caldana PL; Scarpati D; Artuso A; Viglino S
Eur J Gynaecol Oncol; 1983; 4(3):201-4. PubMed ID: 6401032
[TBL] [Abstract][Full Text] [Related]
70. Cervical Cancer Staging: A Resident's Primer: Women's Imaging.
Raithatha A; Papadopoulou I; Stewart V; Barwick TD; Rockall AG; Bharwani N
Radiographics; 2016; 36(3):933-4. PubMed ID: 27163600
[No Abstract] [Full Text] [Related]
71. [The TNM-System and oncologic-radiologic findings].
Golder W
Rofo; 2001 Nov; 173(11):965-8. PubMed ID: 11704904
[No Abstract] [Full Text] [Related]
72. [3D-glass-body-rendering in cervical carcinoma].
Merz E
Ultraschall Med; 2008 Apr; 29(2):125-6. PubMed ID: 18421660
[No Abstract] [Full Text] [Related]
73. Recent progress in cervical oncology.
Kirschbaum TH
Calif Med; 1970 Dec; 113(6):42. PubMed ID: 5486518
[No Abstract] [Full Text] [Related]
74. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer.
Mahantshetty U; Poetter R; Beriwal S; Grover S; Lavanya G; Rai B; Petric P; Tanderup K; Carvalho H; Hegazy N; Mohamed S; Ohno T; Amornwichet N
Radiother Oncol; 2021 Jul; 160():273-284. PubMed ID: 34019918
[TBL] [Abstract][Full Text] [Related]
75. Implications of the new FIGO staging and the role of imaging in cervical cancer.
Kido A; Nakamoto Y
Br J Radiol; 2021 Sep; 94(1125):20201342. PubMed ID: 33989030
[TBL] [Abstract][Full Text] [Related]
76. Imaging and cancer of the cervix in low- and middle-income countries.
Olpin J; Chuang L; Berek J; Gaffney D
Gynecol Oncol Rep; 2018 Aug; 25():115-121. PubMed ID: 30094311
[TBL] [Abstract][Full Text] [Related]
77. Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.
McEvoy SH; Nougaret S; Abu-Rustum NR; Vargas HA; Sadowski EA; Menias CO; Shitano F; Fujii S; Sosa RE; Escalon JG; Sala E; Lakhman Y
Abdom Radiol (NY); 2017 Oct; 42(10):2488-2512. PubMed ID: 28528388
[TBL] [Abstract][Full Text] [Related]
78. Primary vaginal cancer: role of MRI in diagnosis, staging and treatment.
Gardner CS; Sunil J; Klopp AH; Devine CE; Sagebiel T; Viswanathan C; Bhosale PR
Br J Radiol; 2015 Aug; 88(1052):20150033. PubMed ID: 25966291
[TBL] [Abstract][Full Text] [Related]
79. Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment.
Lee M; Lee Y; Hwang KH; Choe W; Park CY
Nucl Med Mol Imaging; 2011 Jun; 45(2):111-6. PubMed ID: 24899989
[TBL] [Abstract][Full Text] [Related]
80. Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer.
Bhoil A; Mittal BR; Bhattacharya A; Santhosh S; Patel F
Indian J Nucl Med; 2013 Oct; 28(4):216-20. PubMed ID: 24379531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
